Disordered growth hormone secretion in fibromyalgia: A review of recent findings and a hypothesized etiology

Zeitschrift fur Rheumatologie

Volumn 57, Issue SUPPL. 2, 1998, Pages 72-76

  Bennett, R M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Fibromyalgia; GH deficiency; GH treatment; Growth hormone; IGF 1; Somatostatin

Indexed keywords

BETA ADRENERGIC RECEPTOR; GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOSTATIN;

ADRENERGIC SYSTEM; ADULT; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROMYALGIA; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONAL THERAPY; HUMAN; HYPERCORTISOLISM; MAJOR CLINICAL STUDY; TREATMENT OUTCOME;

EID: 0032441567     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930050240     Document Type: Conference Paper

References (36)

1. Almqvist O, Thoren M, Saaf M, Eriksson O (1986) Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study. Psychoneuroendocrinology 11:347-352
2. Bagge E, Bengtsson BA, Carlsson L, Carlsson J (1998) Low growth hormone secretion in patients with fibromyalgia - a preliminary report on 10 patients and 10 controls. J Rheumatol 25:145-148
3. Bennett RM (1989) Beyond fibromyalgia: ideas on etiology and treatment. J Rheumatol Suppl 19:185-191
4. Bennett RM, Clark SR, Campbell SM, Burckhardt CS (1992) Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain. Arthritis Rheum 35:1113-1116
5. Bennett RM, Clark SR, Walcyk J (1998) A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 104:227-231
6. Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM (1997) Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. J Rheumatol 24:1384-1389
7. Carette S, Dessureault M, Bëlanger A (1992) Fibromyalgia and sex hormones [letter]. J Rheumatol 19:831
8. Christ ER, Carroll PV, Russell-Jones DL, Sonksen PH (1997) The consequences of growth hormone deficiency in adulthood, and the effects of growth hormone replacement. Schweiz Med Wochenschr 127:1440-1449
9. Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, Sternberg EM, Gold PW, Chrousos GP, Wilder RL (1994) Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 37:1583-1592
10. Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B. Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D (1998) The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults. J Clin Endocrinol Metab 83:107-116
11. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH (1991) Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. Journal of Applied Physiology 70:695-700
12. Cuneo RC, Salomon F, Wiles CM, Hesp R. Sonksen PH (1991) Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength. J Appl Physiol 70:688-694
13. Devesa J, Lima L, Tresguerres JAF (1992) Neuroendocrine control of growth hormone secretion in humans. Trends Endocrinol Metab 3:173-181
14. Esteban N, Loughlin T, Yergey A, Loriaux L (1991) Daily cortisol production rate in man determined by stable isotope dilution, mass spectrometry. JECM:39-45
15. Florini JR, Prinz PN, Vitiello MV, Hintz RL (1985) Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone. J Gerontol 40:2-7
16. Forseth KO, Gran JT, Husby G (1997) A population study of the incidence of fibromyalgia among women aged 26-55 yr. Br J Rheumatol. 36:1318-1323
17. Giusti M, Meinen I, Malagamba D, Cuttica CM, Fattacciu G, Menichini U, Rasore E, Giorduno G (1998) Impact of recombinant human growth hormone treatment on psychological profiles in hypopituitary patients with adult-onset growth hormone deficiency. Eur J Clin Invest 28:13-19
18. Giustina A, Bresciani E, Bossoni S, Chiesa L, Misitano V, Wehrenherg WB, Veldhuis JD (1994) Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency. J Clin Endocrinol Metab 79:1266-1272
19. Griep EN, Boersma JW, de Kloet ER (1993) Growth hormone deficiency and hyperreactivity in patients with primary fibromyalgia syndrome. Br J Rheumatol 32:131
20. Griep EN, Boersma JW, de Kloet ER (1994) Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome. J Rheumatol 21: 2125-2130
21. Lal S, Tolis G, Martin JB, Brown GM, Guyda H (1975) Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone and thyroid hormone in serum of normal men. J Clin Endocrinol Metab 41: 827-832
22. Lima L, Arce V, Diaz MJ, Tresguerres J AF, Devesa J (1993) Glucocorticoids may inhibit growth hormone release by-enhancing β-adrenergic responsiveness in hypothalamic somatostatin neurons. J Clin Endocrinol Metab 76:439-444
23. McCain GA, Tube KS (1989) Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol Suppl 19:154-157
24. McGauley GA, Cuneo RC, Salomon F, Sönksen PH (1990) Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Horm Res 33 Suppl 4:52-54
25. Meiworm L, Deodhar AA, Bennett RM (1996) Pyridostigmine induced enhancement of growth-hormone release in fibromyalgia patients. Arthritis Rheum 39:S277
26. Moldofsky H, Scarisbrick P, England R, Smythe H (1975) Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 37: 341-351
27. Pillemer SR, Bradley LA, Crofford LJ, Moldofsky H, Chrousos GP (1997) The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 40:1928-1939
28. Shahi M, Beshyah SA, Hacken D, Sharp P, Johnston DG, Foale R (1991) Cardiac function and structure in growth hormone deficiency. Br Heart J 66:58-63
29. Skuse D, Albanese A, Stanhope R, Gilmour J, Voss L (1996) A new stress-related syndrome of growth failure and hyperphagia in children, associated with reversibility of growth-hormone insufficiency. Lancet 348:353-358
30. Thorner O (1992) The anterior pituitary. (8. edn), Wilson JD, Foster DW (eds) Philadelphia, WB Saunders, pp 221-310.
31. Valcavi R, Valente F, Dieguez C, Zini M, Procopio M, Portioli I, Ghigo E (1993) Evidence against deletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine. J Clin Endocrinol Metab 77:616-620
32. Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards RH, MacFarlane IA (1997) Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. Clin Endocrinol (Oxf) 47:439-446
33. Waxman J and Zatzkis SM (1986) Fibromyalgia and menopause. Examination of the relationship. Postgrad Med 80:165-167, 170-171
34. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichthroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arth Rheum 33: 160-172
35. Yunus MB, Holt GS, Masi AT, Aldag JC (1988) Fibromyalgia syndrome among the elderly. Comparison with younger patients. J Am Geriatr Soc 36: 987-995
36. Yunus MB and Masi AT (1985) Juvenile primary fibromyalgia syndrome. A clinical study of thirty-three patients and matched normal controls. Arth Rheum 28:138-145